Insights On Enterprise Solutions
-
A New Horizon In AAV cGMP Gene Therapy Manufacturing
3/18/2024
For cell expansion to occur, we use the world-leading cell line: Pro10™ by AskBio. Viralgen is the only company in the world with a license to manufacture for third parties.
-
Small Scale Feasibility
3/15/2024
With a simple quote and 10 mg of your research grade transgene plasmid, Viralgen can perform a small scale feasibility study, including downstream purification.
-
Selecting The Right pDNA Supplier: 10 Key Factors To Consider
3/13/2024
Selecting the right pDNA supplier is a critical decision that can significantly impact the success of your project or research. Consider these 10 key factors to help you make an informed choice.
-
A CDMO’s Checklist For Prospective Clients: Part 3
3/13/2024
In the last entry of our client checklist series, we delve into crucial aspects such as project management, decision-making, MSA negotiations, and building trust in CDMO-client partnerships.
-
A CDMO’s Checklist For Prospective Clients: Part 2
3/13/2024
In Part 2 of our series, we delve deeper into the crucial elements of transparency that prospective clients should consider when partnering with a CDMO, including analytics, documentation, and more.
-
A CDMO’s Checklist For Prospective Clients: Part 1
3/13/2024
Ever wondered about the flip side of client-CDMO dynamics? In this series, discover why transparency is vital for both parties in a fruitful partnership.
-
A Mammalian Suspension Technology For Scalable rAAV Production
3/13/2024
Explore a HEK293 derived animal component-free suspension cell line as the foundation of an up to 2000-liters scalable and robust platform process that increases the speed of AAV manufacturing.
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies
3/11/2024
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Accelerating The Development And Production Of High-Quality Bispecific Antibodies
3/7/2024
bsAbs are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn how an innovative platform offers excellent pairing and significantly enhances productivity and quality.
-
Single-Use Microbial Impactor On A Filling Line
3/6/2024
Discover the advantages of a single-use microbial impactor through a demonstration of its ease of use in an isolator and an explanation of its ability to eliminate false positives.